DermTech Seeks to Tackle Melanoma Testing with Genomic Technology

The La Jolla, Calif.-based firm is developing a test for detecting melanoma and is exploring use of its technology for prostate cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.